Nebivolol Versus Carvedilol in Patients With Heart Failure

Overview

BACKGROUND Beta-blockers improve left ventricular (LV) systolic function and prognosis in patients with chronic heart failure. Both carvedilol and nebivolol have hemodynamic and clinical benefits in chronic heart failure (CHF), but it is unknown whether their pleiotropic properties may play a role in different subgroups of patients with CHF. OBJECTIVE: To compare the effects of nebivolol and carvedilol on LV function and clinical outcome in patients with chronic heart failure and reduced LV systolic function. METHODS: 160 hypertensive CHF patients, LV ejection fraction (EF) 40% and in New York Heart Association (NYHA) functional class II or III were randomly assigned to receive carvedilol or nebivolol therapy for 24 months. At baseline and after 24 months of treatment, all patients underwent clinical evaluation: echocardiogram and 6-minute walking test.

Full Title of Study: “Effects of Nebivolol Versus Carvedilol in Hypertensive Patients With Chronic Heart Failure”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective

Participating in This Clinical Trial

Inclusion Criteria

  • left ventricular ejection fraction (LVEF) < 40%; – symptomatic heart failure with functional New York Heart Association (NYHA) class II or III; – arterial hypertension with systolic blood pressure >140 mmHg and diastolic blood pressure >85 mmHg; – clinical stability without hospital admission for heart failure in the previous 3 months. Exclusion Criteria:

  • history of asthma or severe chronic obstructive pulmonary disease; – severe liver or kidney diseases; – second-degree or third degree heart block without a permanent pacemaker, – sick sinus syndrome, heart rate <60 beat/min, systolic blood pressure <90 mmHg.

Gender Eligibility: All

Minimum Age: 53 Years

Maximum Age: 76 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • IRCCS San Raffaele
  • Overall Official(s)
    • giuseppe rosano, md, Study Director, IRCCS san Raffaele Cardiovascular Research Unit

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.